AF
CNTA

Allworth Financial’s Centessa Pharmaceuticals CNTA Stock Holding History

Allworth Financial’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-275
Closed -$6.88K – 5222
2025
Q4 		$6.88K Buy
+275
New +$6.96K ﹤0.01% 3519

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Allworth Financial's CNTA Position: Q1 2026 in Review

Allworth Financial sold out of Centessa Pharmaceuticals (CNTA) in Q1 2026, closing a stake of 275 shares — an estimated $6.88K sold.

Allworth Financial first reported a position in CNTA in Q4 2025 and held it in 1 quarter. The position peaked at $6.88K in Q4 2025. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Allworth Financial reported no remaining Centessa Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Allworth Financial sold 275 Centessa Pharmaceuticals shares in Q1 2026, an estimated $6.88K.
  • Allworth Financial first reported a position in Centessa Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Allworth Financial's Centessa Pharmaceuticals position peaked at $6.88K in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.